KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Cash from Operations (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Cash from Operations for 16 consecutive years, with 4916000.0 as the latest value for Q4 2025.

Quarterly Cash from Operations rose 198.84% to 4916000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 20115000.0 through Dec 2025, up 138.58% year-over-year, with the annual reading at 20115000.0 for FY2025, 138.58% up from the prior year.
Cash from Operations for Q4 2025 was 4916000.0 at Biolife Solutions, down from 6104000.0 in the prior quarter.
The five-year high for Cash from Operations was 7857000.0 in Q4 2022, with the low at 9917000.0 in Q2 2022.
Average Cash from Operations over 5 years is 148350.0, with a median of 1686000.0 recorded in 2024.
Peak annual rise in Cash from Operations hit 1115.12% in 2022, while the deepest fall reached 535.38% in 2022.
Over 5 years, Cash from Operations stood at 774000.0 in 2021, then surged by 1115.12% to 7857000.0 in 2022, then plummeted by 70.59% to 2311000.0 in 2023, then decreased by 28.82% to 1645000.0 in 2024, then soared by 198.84% to 4916000.0 in 2025.
According to Business Quant data, Cash from Operations over the past three periods came in at 4916000.0, 6104000.0, and 7368000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.